-
1
-
-
65949102794
-
Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity
-
Hongo M., Nagasaki Y., Shoji T. Epidemiology of esophageal cancer: orient to occident. Effects of chronology, geography and ethnicity. J. Gastroenterol. Hepatol. 2009, 24:729-735.
-
(2009)
J. Gastroenterol. Hepatol.
, vol.24
, pp. 729-735
-
-
Hongo, M.1
Nagasaki, Y.2
Shoji, T.3
-
3
-
-
77953222823
-
Circulating microRNAs: novel biomarkers for esophageal cancer
-
Zhou S.-L., Wang L.-D. Circulating microRNAs: novel biomarkers for esophageal cancer. World J. Gastroenterol. 2010, 16:2348.
-
(2010)
World J. Gastroenterol.
, vol.16
, pp. 2348
-
-
Zhou, S.-L.1
Wang, L.-D.2
-
4
-
-
0034943786
-
Skeletonizing en bloc esophagectomy for cancer
-
Collard J.-M., Otte J.-B., Fiasse R., Laterre P.-F., De Kock M., Longueville J., et al. Skeletonizing en bloc esophagectomy for cancer. Ann. Surg. 2001, 234:25.
-
(2001)
Ann. Surg.
, vol.234
, pp. 25
-
-
Collard, J.-M.1
Otte, J.-B.2
Fiasse, R.3
Laterre, P.-F.4
De Kock, M.5
Longueville, J.6
-
5
-
-
0034858057
-
Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world
-
Siewert J.R., Stein H.J., Feith M., Bruecher B.L., Bartels H., Fink U. Histologic tumor type is an independent prognostic parameter in esophageal cancer: lessons from more than 1,000 consecutive resections at a single center in the Western world. Ann. Surg. 2001, 234:360.
-
(2001)
Ann. Surg.
, vol.234
, pp. 360
-
-
Siewert, J.R.1
Stein, H.J.2
Feith, M.3
Bruecher, B.L.4
Bartels, H.5
Fink, U.6
-
6
-
-
38649140487
-
MicroRNA expression profiles of esophageal cancer
-
Feber A., Xi L., Luketich J.D., Pennathur A., Landreneau R.J., Wu M., et al. MicroRNA expression profiles of esophageal cancer. J. Thoracic Cardiovasc. Surg. 2008, 135:255-260.
-
(2008)
J. Thoracic Cardiovasc. Surg.
, vol.135
, pp. 255-260
-
-
Feber, A.1
Xi, L.2
Luketich, J.D.3
Pennathur, A.4
Landreneau, R.J.5
Wu, M.6
-
7
-
-
82255162676
-
MicroRNA involvement in esophageal carcinogenesis
-
David S., Meltzer S.J. MicroRNA involvement in esophageal carcinogenesis. Curr. Opin. Pharmacol. 2011, 11:612-616.
-
(2011)
Curr. Opin. Pharmacol.
, vol.11
, pp. 612-616
-
-
David, S.1
Meltzer, S.J.2
-
8
-
-
66949128313
-
Biomarkers in gastroenterology: between hope and hype comes histopathology
-
Jankowski J.A., Odze R.D. Biomarkers in gastroenterology: between hope and hype comes histopathology. Am. J. Gastroenterol. 2009, 104:1093-1096.
-
(2009)
Am. J. Gastroenterol.
, vol.104
, pp. 1093-1096
-
-
Jankowski, J.A.1
Odze, R.D.2
-
10
-
-
0347988235
-
Nuclear export of microRNA precursors
-
Lund E., Güttinger S., Calado A., Dahlberg J.E., Kutay U. Nuclear export of microRNA precursors. Science 2004, 303:95-98.
-
(2004)
Science
, vol.303
, pp. 95-98
-
-
Lund, E.1
Güttinger, S.2
Calado, A.3
Dahlberg, J.E.4
Kutay, U.5
-
11
-
-
0142165224
-
Functional siRNAs and miRNAs exhibit strand bias
-
Khvorova A., Reynolds A., Jayasena S.D. Functional siRNAs and miRNAs exhibit strand bias. Cell 2003, 115:209-216.
-
(2003)
Cell
, vol.115
, pp. 209-216
-
-
Khvorova, A.1
Reynolds, A.2
Jayasena, S.D.3
-
12
-
-
10744225153
-
Asymmetry in the assembly of the RNAi enzyme complex
-
Schwarz D.S., Hutvágner G., Du T., Xu Z., Aronin N., Zamore P.D. Asymmetry in the assembly of the RNAi enzyme complex. Cell 2003, 115:199-208.
-
(2003)
Cell
, vol.115
, pp. 199-208
-
-
Schwarz, D.S.1
Hutvágner, G.2
Du, T.3
Xu, Z.4
Aronin, N.5
Zamore, P.D.6
-
13
-
-
0347444723
-
MicroRNAs: genomics, biogenesis, mechanism, and function
-
Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
-
(2004)
Cell
, vol.116
, pp. 281-297
-
-
Bartel, D.P.1
-
14
-
-
84958640151
-
The role of oncomirs in the pathogenesis and treatment of breast cancer
-
Hemmatzadeh M., Mohammadi H., Jadidi-Niaragh F., Asghari F., Yousefi M. The role of oncomirs in the pathogenesis and treatment of breast cancer. Biomed. Pharmacother. 2016, 78:129-139.
-
(2016)
Biomed. Pharmacother.
, vol.78
, pp. 129-139
-
-
Hemmatzadeh, M.1
Mohammadi, H.2
Jadidi-Niaragh, F.3
Asghari, F.4
Yousefi, M.5
-
15
-
-
22644435561
-
Increasing incidence of Barrett's oesophagus in the general population
-
van Soest E.M., Dieleman J.P., Siersema P.D., Sturkenboom M.C., Kuipers E.J. Increasing incidence of Barrett's oesophagus in the general population. Gut 2005, 54:1062-1066.
-
(2005)
Gut
, vol.54
, pp. 1062-1066
-
-
van Soest, E.M.1
Dieleman, J.P.2
Siersema, P.D.3
Sturkenboom, M.C.4
Kuipers, E.J.5
-
16
-
-
0034068341
-
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer
-
Farrow D.C., Vaughan T.L., Sweeney C., Gammon M.D., Chow W.-H., Risch H.A., et al. Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer. Cancer Causes Control 2000, 11:231-238.
-
(2000)
Cancer Causes Control
, vol.11
, pp. 231-238
-
-
Farrow, D.C.1
Vaughan, T.L.2
Sweeney, C.3
Gammon, M.D.4
Chow, W.-H.5
Risch, H.A.6
-
17
-
-
0034254576
-
Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma
-
Lagergren J., Bergström R., Adami H.-O., Nyrén O. Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann. Intern. Med. 2000, 133:165-175.
-
(2000)
Ann. Intern. Med.
, vol.133
, pp. 165-175
-
-
Lagergren, J.1
Bergström, R.2
Adami, H.-O.3
Nyrén, O.4
-
18
-
-
0035863438
-
Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors
-
Brown L.M., Hoover R., Silverman D., Baris D., Hayes R., Swanson G.M., et al. Excess incidence of squamous cell esophageal cancer among US Black men: role of social class and other risk factors. Am. J. Epidemiol. 2001, 153:114-122.
-
(2001)
Am. J. Epidemiol.
, vol.153
, pp. 114-122
-
-
Brown, L.M.1
Hoover, R.2
Silverman, D.3
Baris, D.4
Hayes, R.5
Swanson, G.M.6
-
19
-
-
78649887520
-
Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma
-
Zhang C., Wang C., Chen X., Yang C., Li K., Wang J., et al. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin. Chem. 2010, 56:1871-1879.
-
(2010)
Clin. Chem.
, vol.56
, pp. 1871-1879
-
-
Zhang, C.1
Wang, C.2
Chen, X.3
Yang, C.4
Li, K.5
Wang, J.6
-
20
-
-
61349116213
-
Barrett's oesophagus
-
Shaheen N.J., Richter J.E. Barrett's oesophagus. Lancet 2009, 373:850-861.
-
(2009)
Lancet
, vol.373
, pp. 850-861
-
-
Shaheen, N.J.1
Richter, J.E.2
-
21
-
-
70349452273
-
MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma
-
Yang H., Gu J., Wang K.K., Zhang W., Xing J., Chen Z., et al. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin. Cancer Res. 2009, 15:5744-5752.
-
(2009)
Clin. Cancer Res.
, vol.15
, pp. 5744-5752
-
-
Yang, H.1
Gu, J.2
Wang, K.K.3
Zhang, W.4
Xing, J.5
Chen, Z.6
-
22
-
-
84876698299
-
MicroRNA in the pathogenesis and prognosis of esophageal cancer
-
Gu J., Wang Y., Wu X. MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr. Pharm. Des. 2013, 19:1292-1300.
-
(2013)
Curr. Pharm. Des.
, vol.19
, pp. 1292-1300
-
-
Gu, J.1
Wang, Y.2
Wu, X.3
-
23
-
-
65249146132
-
The miR-106b-25 polycistron activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim
-
Kan T., Sato F., Ito T., Matsumura N., David S., Cheng Y., et al. The miR-106b-25 polycistron activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009, 136:1689-1700.
-
(2009)
Gastroenterology
, vol.136
, pp. 1689-1700
-
-
Kan, T.1
Sato, F.2
Ito, T.3
Matsumura, N.4
David, S.5
Cheng, Y.6
-
24
-
-
77953020454
-
The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma
-
Hong L., Han Y., Zhang H., Li M., Gong T., Sun L., et al. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann. Surg. 2010, 251:1056-1063.
-
(2010)
Ann. Surg.
, vol.251
, pp. 1056-1063
-
-
Hong, L.1
Han, Y.2
Zhang, H.3
Li, M.4
Gong, T.5
Sun, L.6
-
25
-
-
77951763151
-
Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC
-
Kimura S., Naganuma S., Susuki D., Hirono Y., Yamaguchi A., Fujieda S., et al. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol. Rep. 2010, 23:1625-1633.
-
(2010)
Oncol. Rep.
, vol.23
, pp. 1625-1633
-
-
Kimura, S.1
Naganuma, S.2
Susuki, D.3
Hirono, Y.4
Yamaguchi, A.5
Fujieda, S.6
-
26
-
-
67651045805
-
MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer
-
Lee K.-H., Goan Y.-G., Hsiao M., Lee C.-H., Jian S.-H., Lin J.-T., et al. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp. Cell Res. 2009, 315:2529-2538.
-
(2009)
Exp. Cell Res.
, vol.315
, pp. 2529-2538
-
-
Lee, K.-H.1
Goan, Y.-G.2
Hsiao, M.3
Lee, C.-H.4
Jian, S.-H.5
Lin, J.-T.6
-
27
-
-
67650664984
-
Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR
-
Ogawa R., Ishiguro H., Kuwabara Y., Kimura M., Mitsui A., Katada T., et al. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med. Mol. Morphol. 2009, 42:102-109.
-
(2009)
Med. Mol. Morphol.
, vol.42
, pp. 102-109
-
-
Ogawa, R.1
Ishiguro, H.2
Kuwabara, Y.3
Kimura, M.4
Mitsui, A.5
Katada, T.6
-
28
-
-
77950877531
-
MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines
-
Tian Y., Luo A., Cai Y., Su Q., Ding F., Chen H., et al. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J. Biol. Chem. 2010, 285:7986-7994.
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 7986-7994
-
-
Tian, Y.1
Luo, A.2
Cai, Y.3
Su, Q.4
Ding, F.5
Chen, H.6
-
29
-
-
79952322000
-
TNF-α is a novel target of miR-19a
-
Liu M., Wang Z., Yang S., Zhang W., He S., Hu C., et al. TNF-α is a novel target of miR-19a. Int. J. Oncol. 2011, 38:1013-1022.
-
(2011)
Int. J. Oncol.
, vol.38
, pp. 1013-1022
-
-
Liu, M.1
Wang, Z.2
Yang, S.3
Zhang, W.4
He, S.5
Hu, C.6
-
30
-
-
80052343196
-
The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma
-
Zhang T., Wang Q., Zhao D., Cui Y., Cao B., Guo L., et al. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin. Sci. 2011, 121:437-447.
-
(2011)
Clin. Sci.
, vol.121
, pp. 437-447
-
-
Zhang, T.1
Wang, Q.2
Zhao, D.3
Cui, Y.4
Cao, B.5
Guo, L.6
-
31
-
-
79960037044
-
MiR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression
-
Ding D.-P., Chen Z.-L., Zhao X.-H., Wang J.-W., Sun J., Wang Z., et al. miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression. Carcinogenesis 2011, 32:1025-1032.
-
(2011)
Carcinogenesis
, vol.32
, pp. 1025-1032
-
-
Ding, D.-P.1
Chen, Z.-L.2
Zhao, X.-H.3
Wang, J.-W.4
Sun, J.5
Wang, Z.6
-
32
-
-
78650944900
-
MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1)
-
Tsuchiya S., Fujiwara T., Sato F., Shimada Y., Tanaka E., Sakai Y., et al. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J. Biol. Chem. 2011, 286:420-428.
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 420-428
-
-
Tsuchiya, S.1
Fujiwara, T.2
Sato, F.3
Shimada, Y.4
Tanaka, E.5
Sakai, Y.6
-
33
-
-
84903756762
-
MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets
-
Huang J., Zhang S.Y., Gao Y.M., Liu Y.F., Liu Y.B., Zhao Z.G., et al. MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: potential biomarkers and therapeutic targets. Cell Prolif. 2014, 47:277-286.
-
(2014)
Cell Prolif.
, vol.47
, pp. 277-286
-
-
Huang, J.1
Zhang, S.Y.2
Gao, Y.M.3
Liu, Y.F.4
Liu, Y.B.5
Zhao, Z.G.6
-
34
-
-
79957990632
-
Feasibility of microRNAs as biomarkers for Barrett's esophagus progression: a pilot cross-sectional phase 2 biomarker study
-
Bansal A., Lee I., Hong X., Anand V., Mathur S., Gaddam S., et al. Feasibility of microRNAs as biomarkers for Barrett's esophagus progression: a pilot cross-sectional phase 2 biomarker study. Am. J. Gastroenterol. 2011, 106:1055-1063.
-
(2011)
Am. J. Gastroenterol.
, vol.106
, pp. 1055-1063
-
-
Bansal, A.1
Lee, I.2
Hong, X.3
Anand, V.4
Mathur, S.5
Gaddam, S.6
-
35
-
-
65649117364
-
MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus
-
Maru D.M., Singh R.R., Hannah C., Albarracin C.T., Li Y.X., Abraham R., et al. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am. J. Pathol. 2009, 174:1940-1948.
-
(2009)
Am. J. Pathol.
, vol.174
, pp. 1940-1948
-
-
Maru, D.M.1
Singh, R.R.2
Hannah, C.3
Albarracin, C.T.4
Li, Y.X.5
Abraham, R.6
-
36
-
-
34250851115
-
A microRNA component of the p53 tumour suppressor network
-
He L., He X., Lim L.P., De Stanchina E., Xuan Z., Liang Y., et al. A microRNA component of the p53 tumour suppressor network. Nature 2007, 447:1130-1134.
-
(2007)
Nature
, vol.447
, pp. 1130-1134
-
-
He, L.1
He, X.2
Lim, L.P.3
De Stanchina, E.4
Xuan, Z.5
Liang, Y.6
-
37
-
-
78651356009
-
MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma
-
Hummel R., Hussey D.J., Michael M.Z., Haier J., Bruewer M., Senninger N., et al. MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann. Surg. Oncol. 2011, 18:253-260.
-
(2011)
Ann. Surg. Oncol.
, vol.18
, pp. 253-260
-
-
Hummel, R.1
Hussey, D.J.2
Michael, M.Z.3
Haier, J.4
Bruewer, M.5
Senninger, N.6
-
39
-
-
48749122914
-
Circulating microRNAs as stable blood-based markers for cancer detection
-
Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. 2008, 105:10513-10518.
-
(2008)
Proc. Natl. Acad. Sci.
, vol.105
, pp. 10513-10518
-
-
Mitchell, P.S.1
Parkin, R.K.2
Kroh, E.M.3
Fritz, B.R.4
Wyman, S.K.5
Pogosova-Agadjanyan, E.L.6
-
40
-
-
53349177819
-
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases
-
Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., et al. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18:997-1006.
-
(2008)
Cell Res.
, vol.18
, pp. 997-1006
-
-
Chen, X.1
Ba, Y.2
Ma, L.3
Cai, X.4
Yin, Y.5
Wang, K.6
-
41
-
-
84892806594
-
Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer
-
Tanaka K., Miyata H., Yamasaki M., Sugimura K., Takahashi T., Kurokawa Y., et al. Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. Ann. Surg. Oncol. 2013, 20:607-615.
-
(2013)
Ann. Surg. Oncol.
, vol.20
, pp. 607-615
-
-
Tanaka, K.1
Miyata, H.2
Yamasaki, M.3
Sugimura, K.4
Takahashi, T.5
Kurokawa, Y.6
-
42
-
-
79959736325
-
Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma
-
Komatsu S., Ichikawa D., Takeshita H., Tsujiura M., Morimura R., Nagata H., et al. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 2011, 105:104-111.
-
(2011)
Br. J. Cancer
, vol.105
, pp. 104-111
-
-
Komatsu, S.1
Ichikawa, D.2
Takeshita, H.3
Tsujiura, M.4
Morimura, R.5
Nagata, H.6
-
43
-
-
84861437376
-
Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma
-
Komatsu S., Ichikawa D., Takeshita H., Konishi H., Nagata H., Hirajima S., et al. Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma. Expert Opin. Biol. Ther. 2012, 12:S53-S59.
-
(2012)
Expert Opin. Biol. Ther.
, vol.12
, pp. S53-S59
-
-
Komatsu, S.1
Ichikawa, D.2
Takeshita, H.3
Konishi, H.4
Nagata, H.5
Hirajima, S.6
-
45
-
-
84953407841
-
Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer
-
Kestens C., Siersema P.D., van Baal J.W. Current understanding of the functional roles of aberrantly expressed microRNAs in esophageal cancer. World J. Gastroenterol. 2016, 22:1.
-
(2016)
World J. Gastroenterol.
, vol.22
, pp. 1
-
-
Kestens, C.1
Siersema, P.D.2
van Baal, J.W.3
-
46
-
-
84879842127
-
MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma
-
Wang N., Zhang C.-q., He J.-h., Duan X.-f., Wang Y.-y., Ji X., et al. MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig. Dis. Sci. 2013, 58:1863-1870.
-
(2013)
Dig. Dis. Sci.
, vol.58
, pp. 1863-1870
-
-
Wang, N.1
Zhang, C.-Q.2
He, J.-H.3
Duan, X.-F.4
Wang, Y.-Y.5
Ji, X.6
-
47
-
-
84865554193
-
Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer
-
Alder H., Taccioli C., Chen H., Jiang Y., Smalley K.J., Fadda P., et al. Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis 2012.
-
(2012)
Carcinogenesis
-
-
Alder, H.1
Taccioli, C.2
Chen, H.3
Jiang, Y.4
Smalley, K.J.5
Fadda, P.6
-
48
-
-
68249139817
-
MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC
-
Sasayama T., Nishihara M., Kondoh T., Hosoda K., Kohmura E. MicroRNA-10b is overexpressed in malignant glioma and associated with tumor invasive factors, uPAR and RhoC. Int. J. Cancer 2009, 125:1407-1413.
-
(2009)
Int. J. Cancer
, vol.125
, pp. 1407-1413
-
-
Sasayama, T.1
Nishihara, M.2
Kondoh, T.3
Hosoda, K.4
Kohmura, E.5
-
49
-
-
77955591555
-
MicroRNAs and their target gene networks in breast cancer
-
Lal E.O.D.A. MicroRNAs and their target gene networks in breast cancer. Breast Cancer Res. 2010, 12:201.
-
(2010)
Breast Cancer Res.
, vol.12
, pp. 201
-
-
Lal, E.O.D.A.1
-
50
-
-
84958245014
-
Predictive value of serum miR-10b, miR-29c, and miR-205 as promising biomarkers in esophageal squamous cell carcinoma screening
-
Xu H., Yao Y., Meng F., Qian X., Jiang X., Li X., et al. Predictive value of serum miR-10b, miR-29c, and miR-205 as promising biomarkers in esophageal squamous cell carcinoma screening. Medicine (Baltimore). 2015, 94:e1558.
-
(2015)
Medicine (Baltimore).
, vol.94
-
-
Xu, H.1
Yao, Y.2
Meng, F.3
Qian, X.4
Jiang, X.5
Li, X.6
-
51
-
-
79953187233
-
MicroRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin
-
Chen Z.-l., Zhao X.-h., Wang J.-w., Li B.-z., Wang Z., Sun J., et al. microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J. Biol. Chem. 2011, 286:10725-10734.
-
(2011)
J. Biol. Chem.
, vol.286
, pp. 10725-10734
-
-
Chen, Z.-L.1
Zhao, X.-H.2
Wang, J.-W.3
Li, B.-Z.4
Wang, Z.5
Sun, J.6
-
52
-
-
84889679431
-
Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy
-
Yu H., Duan B., Jiang L., Lin M., Sheng H., Huang J., et al. Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy. Am. J. Trans. Res. 2014, 6:71.
-
(2014)
Am. J. Trans. Res.
, vol.6
, pp. 71
-
-
Yu, H.1
Duan, B.2
Jiang, L.3
Lin, M.4
Sheng, H.5
Huang, J.6
-
53
-
-
1642617693
-
PI3K/Akt signalling pathway and cancer
-
Vara J.Á.F., Casado E., de Castro J., Cejas P., Belda-Iniesta C., González-Barón M. PI3K/Akt signalling pathway and cancer. Cancer Treatment Rev. 2004, 30:193-204.
-
(2004)
Cancer Treatment Rev.
, vol.30
, pp. 193-204
-
-
Vara, J.Á.F.1
Casado, E.2
de Castro, J.3
Cejas, P.4
Belda-Iniesta, C.5
González-Barón, M.6
-
54
-
-
84878831559
-
Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway
-
Burris H.A. Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway. Cancer Chemother. Pharmacol. 2013, 71:829-842.
-
(2013)
Cancer Chemother. Pharmacol.
, vol.71
, pp. 829-842
-
-
Burris, H.A.1
-
55
-
-
84888250297
-
Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis
-
Matsuzaki J., Suzuki H., Tsugawa H., Watanabe M., Hossain S., Arai E., et al. Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis. Gastroenterology 2013, 145:1300-1311.
-
(2013)
Gastroenterology
, vol.145
, pp. 1300-1311
-
-
Matsuzaki, J.1
Suzuki, H.2
Tsugawa, H.3
Watanabe, M.4
Hossain, S.5
Arai, E.6
-
56
-
-
0034708122
-
The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans
-
Reinhart B.J., Slack F.J., Basson M., Pasquinelli A.E., Bettinger J.C., Rougvie A.E., et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906.
-
(2000)
Nature
, vol.403
, pp. 901-906
-
-
Reinhart, B.J.1
Slack, F.J.2
Basson, M.3
Pasquinelli, A.E.4
Bettinger, J.C.5
Rougvie, A.E.6
-
57
-
-
84859158298
-
Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma
-
Liu Q., Lv G.-d., Qin X., Gen Y.-h., Zheng S.-t., Liu T., et al. Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. Mol. Biol. Rep. 2012, 39:1239-1246.
-
(2012)
Mol. Biol. Rep.
, vol.39
, pp. 1239-1246
-
-
Liu, Q.1
Lv, G.-D.2
Qin, X.3
Gen, Y.-H.4
Zheng, S.-T.5
Liu, T.6
-
58
-
-
84963934428
-
Tumor suppressor microRNAs: targeted molecules and signaling pathways in breast cancer
-
Asghari F., Haghnavaz N., Baradaran B., Hemmatzadeh M., Kazemi T. Tumor suppressor microRNAs: targeted molecules and signaling pathways in breast cancer. Biomed. Pharmacother. 2016, 81:305-317.
-
(2016)
Biomed. Pharmacother.
, vol.81
, pp. 305-317
-
-
Asghari, F.1
Haghnavaz, N.2
Baradaran, B.3
Hemmatzadeh, M.4
Kazemi, T.5
-
59
-
-
84866396210
-
Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma
-
Sugimura K., Miyata H., Tanaka K., Hamano R., Takahashi T., Kurokawa Y., et al. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin. Cancer Res. 2012, 18:5144-5153.
-
(2012)
Clin. Cancer Res.
, vol.18
, pp. 5144-5153
-
-
Sugimura, K.1
Miyata, H.2
Tanaka, K.3
Hamano, R.4
Takahashi, T.5
Kurokawa, Y.6
-
60
-
-
80054774985
-
J. Li. Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer
-
Li X., Lin R. J. Li. Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig. Dis. Sci. 2011, 56:2849-2856.
-
(2011)
Dig. Dis. Sci.
, vol.56
, pp. 2849-2856
-
-
Li, X.1
Lin, R.2
-
61
-
-
83555177355
-
MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor
-
gutjnl-2011-300178
-
Kong K.L., Kwong D.L.W., Chan T.H.-M., Law S.Y.-K., Chen L., Li Y., et al. MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor. Gut 2011, gutjnl-2011-300178.
-
(2011)
Gut
-
-
Kong, K.L.1
Kwong, D.L.W.2
Chan, T.H.-M.3
Law, S.Y.-K.4
Chen, L.5
Li, Y.6
-
62
-
-
84864987437
-
Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma
-
Isozaki Y., Hoshino I., Nohata N., Kinoshita T., Akutsu Y., Hanari N., et al. Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. Int. J. Oncol. 2012, 41:985-994.
-
(2012)
Int. J. Oncol.
, vol.41
, pp. 985-994
-
-
Isozaki, Y.1
Hoshino, I.2
Nohata, N.3
Kinoshita, T.4
Akutsu, Y.5
Hanari, N.6
-
63
-
-
77953414582
-
MiR-145-mediated suppression of cell growth, invasion and metastasis
-
Sachdeva M., Mo Y.-Y. miR-145-mediated suppression of cell growth, invasion and metastasis. Am. J. Trans. Res. 2010, 2:170.
-
(2010)
Am. J. Trans. Res.
, vol.2
, pp. 170
-
-
Sachdeva, M.1
Mo, Y.-Y.2
-
64
-
-
37548999684
-
Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer
-
Sempere L.F., Christensen M., Silahtaroglu A., Bak M., Heath C.V., Schwartz G., et al. Altered MicroRNA expression confined to specific epithelial cell subpopulations in breast cancer. Cancer Res. 2007, 67:11612-11620.
-
(2007)
Cancer Res.
, vol.67
, pp. 11612-11620
-
-
Sempere, L.F.1
Christensen, M.2
Silahtaroglu, A.3
Bak, M.4
Heath, C.V.5
Schwartz, G.6
-
65
-
-
62549148270
-
P53 represses c-Myc through induction of the tumor suppressor miR-145
-
Sachdeva M., Zhu S., Wu F., Wu H., Walia V., Kumar S., et al. p53 represses c-Myc through induction of the tumor suppressor miR-145. Proc. Natl. Acad. Sci. 2009, 106:3207-3212.
-
(2009)
Proc. Natl. Acad. Sci.
, vol.106
, pp. 3207-3212
-
-
Sachdeva, M.1
Zhu, S.2
Wu, F.3
Wu, H.4
Walia, V.5
Kumar, S.6
-
66
-
-
77956181723
-
MiR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma
-
Kano M., Seki N., Kikkawa N., Fujimura L., Hoshino I., Akutsu Y., et al. miR-145, miR-133a and miR-133b: Tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer 2010, 127:2804-2814.
-
(2010)
Int. J. Cancer
, vol.127
, pp. 2804-2814
-
-
Kano, M.1
Seki, N.2
Kikkawa, N.3
Fujimura, L.4
Hoshino, I.5
Akutsu, Y.6
-
67
-
-
20244381388
-
Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma
-
Hashimoto Y., Ito T., Inoue H., Okumura T., Tanaka E., Tsunoda S., et al. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Clin. Cancer Res. 2005, 11:2597-2605.
-
(2005)
Clin. Cancer Res.
, vol.11
, pp. 2597-2605
-
-
Hashimoto, Y.1
Ito, T.2
Inoue, H.3
Okumura, T.4
Tanaka, E.5
Tsunoda, S.6
-
68
-
-
51349157982
-
The MYCN oncogene is a direct target of miR-34a
-
Wei J.S., Song Y.K., Durinck S., Chen Q.-R., Cheuk A.T.C., Tsang P., et al. The MYCN oncogene is a direct target of miR-34a. Oncogene 2008, 27:5204-5213.
-
(2008)
Oncogene
, vol.27
, pp. 5204-5213
-
-
Wei, J.S.1
Song, Y.K.2
Durinck, S.3
Chen, Q.-R.4
Cheuk, A.T.C.5
Tsang, P.6
-
69
-
-
84856347212
-
Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells
-
Li J., Wang K., Chen X., Meng H., Song M., Wang Y., et al. Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells. BMC Mol. Biol. 2012, 13:4.
-
(2012)
BMC Mol. Biol.
, vol.13
, pp. 4
-
-
Li, J.1
Wang, K.2
Chen, X.3
Meng, H.4
Song, M.5
Wang, Y.6
-
70
-
-
34250868124
-
Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest
-
Tarasov V., Jung P., Verdoodt B., Lodygin D., Epanchintsev A., Menssen A., et al. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell cycle. 2007, 6:1586-1593.
-
(2007)
Cell cycle.
, vol.6
, pp. 1586-1593
-
-
Tarasov, V.1
Jung, P.2
Verdoodt, B.3
Lodygin, D.4
Epanchintsev, A.5
Menssen, A.6
-
71
-
-
84867313655
-
Drug resistance-related microRNAs in esophageal cancer
-
Hong L., Han Y., Lu Q., Zhang H., Zhao Q., Wu K., et al. Drug resistance-related microRNAs in esophageal cancer. Expert Opin. Biol. Ther. 2012, 12:1487-1494.
-
(2012)
Expert Opin. Biol. Ther.
, vol.12
, pp. 1487-1494
-
-
Hong, L.1
Han, Y.2
Lu, Q.3
Zhang, H.4
Zhao, Q.5
Wu, K.6
-
72
-
-
79952067801
-
Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells
-
Hummel R., Watson D.I., Smith C., Kist J., Michael M.Z., Haier J., et al. Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J. Gastrointest. Surg. 2011, 15:429-438.
-
(2011)
J. Gastrointest. Surg.
, vol.15
, pp. 429-438
-
-
Hummel, R.1
Watson, D.I.2
Smith, C.3
Kist, J.4
Michael, M.Z.5
Haier, J.6
-
73
-
-
80052985516
-
Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer
-
Gonzales J.C., Fink L.M., Goodman O.B., Symanowski J.T., Vogelzang N.J., Ward D.C. Comparison of circulating MicroRNA 141 to circulating tumor cells, lactate dehydrogenase, and prostate-specific antigen for determining treatment response in patients with metastatic prostate cancer. Clin. Genitourin. Cancer 2011, 9:39-45.
-
(2011)
Clin. Genitourin. Cancer
, vol.9
, pp. 39-45
-
-
Gonzales, J.C.1
Fink, L.M.2
Goodman, O.B.3
Symanowski, J.T.4
Vogelzang, N.J.5
Ward, D.C.6
-
74
-
-
79960571788
-
Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer
-
Agaoglu F.Y., Kovancilar M., Dizdar Y., Darendeliler E., Holdenrieder S., Dalay N., et al. Investigation of miR-21, miR-141, and miR-221 in blood circulation of patients with prostate cancer. Tumor Biol. 2011, 32:583-588.
-
(2011)
Tumor Biol.
, vol.32
, pp. 583-588
-
-
Agaoglu, F.Y.1
Kovancilar, M.2
Dizdar, Y.3
Darendeliler, E.4
Holdenrieder, S.5
Dalay, N.6
-
75
-
-
79955499785
-
MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma
-
Imanaka Y., Tsuchiya S., Sato F., Shimada Y., Shimizu K., Tsujimoto G. MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J. Hum. Genet. 2011, 56:270-276.
-
(2011)
J. Hum. Genet.
, vol.56
, pp. 270-276
-
-
Imanaka, Y.1
Tsuchiya, S.2
Sato, F.3
Shimada, Y.4
Shimizu, K.5
Tsujimoto, G.6
-
76
-
-
84856812740
-
MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A
-
Urbich C., Kaluza D., Frömel T., Knau A., Bennewitz K., Boon R.A., et al. MicroRNA-27a/b controls endothelial cell repulsion and angiogenesis by targeting semaphorin 6A. Blood 2012, 119:1607-1616.
-
(2012)
Blood
, vol.119
, pp. 1607-1616
-
-
Urbich, C.1
Kaluza, D.2
Frömel, T.3
Knau, A.4
Bennewitz, K.5
Boon, R.A.6
-
77
-
-
80053453586
-
MiR-27a regulation of SCFFbw7 in cell division control and cancer
-
3232-3232
-
Spruck C. miR-27a regulation of SCFFbw7 in cell division control and cancer. Cell Cycle 2011, 10. 3232-3232.
-
(2011)
Cell Cycle
, vol.10
-
-
Spruck, C.1
-
78
-
-
77956183846
-
Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma
-
Zhang H., Li M., Han Y., Hong L., Gong T., Sun L., et al. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig. Dis. Sci. 2010, 55:2545-2551.
-
(2010)
Dig. Dis. Sci.
, vol.55
, pp. 2545-2551
-
-
Zhang, H.1
Li, M.2
Han, Y.3
Hong, L.4
Gong, T.5
Sun, L.6
-
79
-
-
84855210220
-
Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296
-
Langenkamp E., Zwiers P.J., Moorlag H.E., Leenders W.P., Croix B.S., Molema G. Vascular endothelial growth factor receptor 2 inhibition in-vivo affects tumor vasculature in a tumor type-dependent way and downregulates vascular endothelial growth factor receptor 2 protein without a prominent role for miR-296. Anticancer Drugs 2012, 23:161-172.
-
(2012)
Anticancer Drugs
, vol.23
, pp. 161-172
-
-
Langenkamp, E.1
Zwiers, P.J.2
Moorlag, H.E.3
Leenders, W.P.4
Croix, B.S.5
Molema, G.6
-
80
-
-
84055217953
-
J. Peters. MicroRNAs 296 and 298 are imprinted and part of the GNAS/Gnas cluster and miR-296 targets IKBKE and Tmed9
-
Robson J.E., Eaton S.A., Underhill P., Williams D. J. Peters. MicroRNAs 296 and 298 are imprinted and part of the GNAS/Gnas cluster and miR-296 targets IKBKE and Tmed9. RNA 2012, 18:135-144.
-
(2012)
RNA
, vol.18
, pp. 135-144
-
-
Robson, J.E.1
Eaton, S.A.2
Underhill, P.3
Williams, D.4
-
81
-
-
79960685445
-
A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA
-
Cazanave S.C., Mott J.L., Elmi N.A., Bronk S.F., Masuoka H.C., Charlton M.R., et al. A role for miR-296 in the regulation of lipoapoptosis by targeting PUMA. J. Lipid Res. 2011, 52:1517-1525.
-
(2011)
J. Lipid Res.
, vol.52
, pp. 1517-1525
-
-
Cazanave, S.C.1
Mott, J.L.2
Elmi, N.A.3
Bronk, S.F.4
Masuoka, H.C.5
Charlton, M.R.6
-
82
-
-
84922953059
-
Alteration of miRNA expression correlates with lifestyle, social and environmental determinants in esophageal carcinoma
-
Stanitz E., Juhasz K., Gombos K., Gocze K., Toth C., Kiss I. Alteration of miRNA expression correlates with lifestyle, social and environmental determinants in esophageal carcinoma. Anticancer Res. 2015, 35:1091-1097.
-
(2015)
Anticancer Res.
, vol.35
, pp. 1091-1097
-
-
Stanitz, E.1
Juhasz, K.2
Gombos, K.3
Gocze, K.4
Toth, C.5
Kiss, I.6
-
83
-
-
84955265711
-
The role of microRNA in esophageal squamous cell carcinoma
-
Harada K., Baba Y., Ishimoto T., Shigaki H., Kosumi K., Yoshida N., et al. The role of microRNA in esophageal squamous cell carcinoma. J. Gastroenterol. 2016, 1-11.
-
(2016)
J. Gastroenterol.
, pp. 1-11
-
-
Harada, K.1
Baba, Y.2
Ishimoto, T.3
Shigaki, H.4
Kosumi, K.5
Yoshida, N.6
-
84
-
-
84863432560
-
CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma
-
Suzuki S., Yokobori T., Tanaka N., Sakai M., Sano A., Inose T., et al. CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma. Oncol. Rep. 2012, 28:465-472.
-
(2012)
Oncol. Rep.
, vol.28
, pp. 465-472
-
-
Suzuki, S.1
Yokobori, T.2
Tanaka, N.3
Sakai, M.4
Sano, A.5
Inose, T.6
-
85
-
-
84872270291
-
MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1
-
Yokobori T., Suzuki S., Tanaka N., Inose T., Sohda M., Sano A., et al. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci. 2013, 104:48-54.
-
(2013)
Cancer Sci.
, vol.104
, pp. 48-54
-
-
Yokobori, T.1
Suzuki, S.2
Tanaka, N.3
Inose, T.4
Sohda, M.5
Sano, A.6
-
86
-
-
79953108471
-
MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells
-
(10.1186)
-
Matsushima K., Isomoto H., Yamaguchi N., Inoue N., Machida H., Nakayama T., et al. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. J. Transl. Med. 2011, 9. (10.1186).
-
(2011)
J. Transl. Med.
, vol.9
-
-
Matsushima, K.1
Isomoto, H.2
Yamaguchi, N.3
Inoue, N.4
Machida, H.5
Nakayama, T.6
-
87
-
-
84925852915
-
The role of hypoxia-Induced miR-210 in cancer progression
-
Dang K., Myers K.A. The role of hypoxia-Induced miR-210 in cancer progression. Int. J. Mol. Sci. 2015, 16:6353-6372.
-
(2015)
Int. J. Mol. Sci.
, vol.16
, pp. 6353-6372
-
-
Dang, K.1
Myers, K.A.2
-
88
-
-
80053360154
-
MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B
-
Liffers S.-T., Munding J.B., Vogt M., Kuhlmann J.D., Verdoodt B., Nambiar S., et al. MicroRNA-148a is down-regulated in human pancreatic ductal adenocarcinomas and regulates cell survival by targeting CDC25B. Lab. Invest. 2011, 91:1472-1479.
-
(2011)
Lab. Invest.
, vol.91
, pp. 1472-1479
-
-
Liffers, S.-T.1
Munding, J.B.2
Vogt, M.3
Kuhlmann, J.D.4
Verdoodt, B.5
Nambiar, S.6
-
89
-
-
80053987030
-
MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer
-
Zhang H., Li Y., Huang Q., Ren X., Hu H., Sheng H., et al. MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ. 2011, 18:1702-1710.
-
(2011)
Cell Death Differ.
, vol.18
, pp. 1702-1710
-
-
Zhang, H.1
Li, Y.2
Huang, Q.3
Ren, X.4
Hu, H.5
Sheng, H.6
-
90
-
-
80053257151
-
Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia
-
Feng D.D., Zhang H., Zhang P., Zheng Y.S., Zhang X.J., Han B.W., et al. Down-regulated miR-331-5p and miR-27a are associated with chemotherapy resistance and relapse in leukaemia. J. Cell. Mol. Med. 2011, 15:2164-2175.
-
(2011)
J. Cell. Mol. Med.
, vol.15
, pp. 2164-2175
-
-
Feng, D.D.1
Zhang, H.2
Zhang, P.3
Zheng, Y.S.4
Zhang, X.J.5
Han, B.W.6
-
91
-
-
84864865233
-
MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines
-
Wang Y.-S., Wang Y.-H., Xia H.-P., Zhou S.-W., Schmid-Bindert G., Zhou C.-C. MicroRNA-214 regulates the acquired resistance to gefitinib via the PTEN/AKT pathway in EGFR-mutant cell lines. Asian Pac. J. Cancer Prev. 2012, 13:255-260.
-
(2012)
Asian Pac. J. Cancer Prev.
, vol.13
, pp. 255-260
-
-
Wang, Y.-S.1
Wang, Y.-H.2
Xia, H.-P.3
Zhou, S.-W.4
Schmid-Bindert, G.5
Zhou, C.-C.6
-
92
-
-
29144470346
-
Real-time quantification of microRNAs by stem-loop RT-PCR
-
e179-e179
-
Chen C., Ridzon D.A., Broomer A.J., Zhou Z., Lee D.H., Nguyen J.T., et al. Real-time quantification of microRNAs by stem-loop RT-PCR. Nucleic Acids Res. 2005, 33. e179-e179.
-
(2005)
Nucleic Acids Res.
, vol.33
-
-
Chen, C.1
Ridzon, D.A.2
Broomer, A.J.3
Zhou, Z.4
Lee, D.H.5
Nguyen, J.T.6
-
93
-
-
84876715427
-
MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options
-
Fassan M., Baffa R., Kiss A., Zaninotto G., Rugge M. MicroRNA dysregulation in esophageal neoplasia: the biological rationale for novel therapeutic options. Curr. Pharm. Des. 2013, 19:1236-1241.
-
(2013)
Curr. Pharm. Des.
, vol.19
, pp. 1236-1241
-
-
Fassan, M.1
Baffa, R.2
Kiss, A.3
Zaninotto, G.4
Rugge, M.5
-
94
-
-
77957361864
-
Targeting microRNAs in cancer: rationale, strategies and challenges
-
Garzon R., Marcucci G., Croce C.M. Targeting microRNAs in cancer: rationale, strategies and challenges. Nat. Rev. Drug Discov. 2010, 9:775-789.
-
(2010)
Nat. Rev. Drug Discov.
, vol.9
, pp. 775-789
-
-
Garzon, R.1
Marcucci, G.2
Croce, C.M.3
-
95
-
-
84883758912
-
MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response
-
Odenthal M., Bollschweiler E., Grimminger P., Schröder W., Brabender J., Drebber U., et al. MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response. Int. J. Cancer 2013, 133:2454-2463.
-
(2013)
Int. J. Cancer
, vol.133
, pp. 2454-2463
-
-
Odenthal, M.1
Bollschweiler, E.2
Grimminger, P.3
Schröder, W.4
Brabender, J.5
Drebber, U.6
-
96
-
-
84858379476
-
MicroRNAs in stress signaling and human disease
-
Mendell J.T., Olson E.N. MicroRNAs in stress signaling and human disease. Cell 2012, 148:1172-1187.
-
(2012)
Cell
, vol.148
, pp. 1172-1187
-
-
Mendell, J.T.1
Olson, E.N.2
-
97
-
-
81155124248
-
Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment
-
Elsevier
-
Sandhu S., Garzon R. Potential applications of microRNAs in cancer diagnosis, prognosis, and treatment. Seminars in oncology 2011, 781-787. Elsevier.
-
(2011)
Seminars in oncology
, pp. 781-787
-
-
Sandhu, S.1
Garzon, R.2
-
98
-
-
83255194160
-
Chemical modification and design of anti-miRNA oligonucleotides
-
Lennox K., Behlke M. Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther. 2011, 18:1111-1120.
-
(2011)
Gene Ther.
, vol.18
, pp. 1111-1120
-
-
Lennox, K.1
Behlke, M.2
-
99
-
-
84871346487
-
Clinical applications for microRNAs in cancer
-
Nana-Sinkam S., Croce C. Clinical applications for microRNAs in cancer. Clin. Pharmacol. Ther. 2013, 93:98-104.
-
(2013)
Clin. Pharmacol. Ther.
, vol.93
, pp. 98-104
-
-
Nana-Sinkam, S.1
Croce, C.2
-
100
-
-
84863906869
-
MicroRNAs as therapeutic targets and their potential applications in cancer therapy
-
Cho W.C. MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Expert Opin. Ther. Targets 2012, 16:747-759.
-
(2012)
Expert Opin. Ther. Targets
, vol.16
, pp. 747-759
-
-
Cho, W.C.1
|